Spero Therapeutics, Inc. (SPRO) has 20 已知的内部人和机构持有人记录. 最大持有人为 GSK PLC 持有 9,190,606 股. 其他重要持有人包括 Aquilo Capital, L.P. 和 Aquilo Capital Management, LLC.
过去12个月,内部人进行了 18 笔交易,涉及 SPRO 股票 — 11 笔买入 (价值为 $1.42M) 和 7 笔卖出 (价值为 $335.28K). 内部人买入超过卖出,可能表明对公司前景有信心.
SPRO 內部人持股
最大持股人
GSK PLC
9,190,606 股
主要內部人持股
| # |
姓名 |
职位 |
持股数量 |
最近申报日期 |
相对规模 |
| 1 |
Gsk Plc |
Director |
9,190,606 |
2022-11-14 |
|
| 2 |
Aquilo Capital, L.p. |
Director |
5,321,231 |
2022-04-28 |
|
| 3 |
Aquilo Capital Management, Llc |
10 Percent Owner |
3,419,435 |
2022-09-26 |
|
| 4 |
Glaxosmithkline Plc |
10 Percent Owner |
1,934,006 |
2018-07-17 |
|
| 5 |
Shukla Sath |
CEO & President |
1,892,216 |
2025-02-05 |
|
| 6 |
Graham Holdings Co |
10 Percent Owner |
1,428,094 |
2015-11-02 |
|
| 7 |
Rajavelu Esther |
See Remarks |
1,012,091 |
2026-02-09 |
|
| 8 |
Hamed Kamal |
Chief Medical Officer |
816,192 |
2024-02-05 |
|
| 9 |
Keutzer Timothy |
Chief Operating Officer |
742,506 |
2026-02-09 |
|
| 10 |
Mahadevia Ankit |
Director |
703,294 |
2025-09-03 |
|
| 11 |
Joseph Tamara L |
Chief Legal Officer |
562,521 |
2024-02-05 |
|
| 12 |
Deshpande Milind |
Director |
91,454 |
2025-06-16 |
|
| 13 |
Thomas Frank E |
Director |
75,000 |
2025-06-16 |
|
| 14 |
Pottage John C Jr |
Director |
75,000 |
2025-06-16 |
|
| 15 |
Vink Patrick V.j.j. |
Director |
75,000 |
2025-06-16 |
|
| 16 |
Tregoning Kathleen |
Director |
75,000 |
2025-06-16 |
|
| 17 |
Smith Cynthia |
Director |
75,000 |
2025-06-16 |
|
| 18 |
Jackson Scott Thomas |
Director |
75,000 |
2025-06-16 |
|
| 19 |
Sendek Joel |
Chief Financial Officer |
65,000 |
2019-01-02 |
|
| 20 |
Melnick David A. |
Chief Medical Officer |
53,190 |
2022-02-03 |
|
近期交易 (过去12个月)
| 日期 |
姓名 |
职位 |
类型 |
股数 |
股价 |
总价值 |
| 2026-02-06 |
Rajavelu Esther |
See Remarks |
知情卖出 |
50,816 |
$2.36 |
$119.93K |
| 2026-02-06 |
Keutzer Timothy |
Chief Operating Officer |
知情卖出 |
18,652 |
$2.36 |
$44.02K |
| 2026-02-04 |
Keutzer Timothy |
Chief Operating Officer |
知情卖出 |
3,471 |
$2.24 |
$7.78K |
| 2026-02-03 |
Keutzer Timothy |
Chief Operating Officer |
知情卖出 |
24,224 |
$2.14 |
$51.84K |
| 2026-02-02 |
Keutzer Timothy |
Chief Operating Officer |
限制性股票授予 (RSU) |
137,000 |
$2.23 |
$305.51K |
| 2026-02-02 |
Rajavelu Esther |
See Remarks |
限制性股票授予 (RSU) |
498,000 |
$2.23 |
$1.11M |
| 2025-11-07 |
Rajavelu Esther |
See Remarks |
知情卖出 |
40,270 |
$2.37 |
$95.44K |
| 2025-08-28 |
Keutzer Timothy |
Chief Operating Officer |
知情卖出 |
1,695 |
$1.97 |
$3.34K |
| 2025-08-28 |
Mahadevia Ankit |
Director |
知情卖出 |
6,572 |
$1.97 |
$12.95K |
| 2025-06-12 |
Tregoning Kathleen |
Director |
限制性股票授予 (RSU) |
20,000 |
- |
- |
| 2025-06-12 |
Mahadevia Ankit |
Director |
限制性股票授予 (RSU) |
20,000 |
- |
- |
| 2025-06-12 |
Smith Cynthia |
Director |
限制性股票授予 (RSU) |
20,000 |
- |
- |
| 2025-06-12 |
Jackson Scott Thomas |
Director |
限制性股票授予 (RSU) |
20,000 |
- |
- |
| 2025-06-12 |
Vink Patrick V.j.j. |
Director |
限制性股票授予 (RSU) |
20,000 |
- |
- |
| 2025-06-12 |
Deshpande Milind |
Director |
限制性股票授予 (RSU) |
20,000 |
- |
- |
| 2025-06-12 |
Pottage John C Jr |
Director |
限制性股票授予 (RSU) |
20,000 |
- |
- |
| 2025-06-12 |
Thomas Frank E |
Director |
限制性股票授予 (RSU) |
20,000 |
- |
- |
| 2025-05-02 |
Rajavelu Esther |
See Remarks |
限制性股票授予 (RSU) |
185,000 |
- |
- |